Lucy Scientific Discovery Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	0.02	0.01	-	-	-
Cost of Revenue	0.01	0	-	-	-
Gross Profit	0.01	0	-	-	-
Selling, General & Admin	7.21	5.77	3.47	2.68	2.8
Research & Development	-	-	-	-0.17	-0.5
Operating Expenses	7.21	5.77	3.47	2.51	2.3
Operating Income	-7.2	-5.77	-3.47	-2.51	-2.3
Interest Expense	-1.46	-1.97	-2.06	-2.36	-0.28
Other Non Operating Income (Expenses)	0.2	0	-0.32	-0.06	-
EBT Excluding Unusual Items	-8.46	-7.73	-5.86	-4.93	-2.58
Asset Writedown	-0.08	-0.08	-	-	-
Other Unusual Items	-1.69	-1.18	-	0.2	-0.42
Pretax Income	-10.23	-8.99	-5.86	-4.73	-3
Net Income	-11.3	-8.99	-5.86	-4.73	-3
Net Income to Common	-11.3	-8.99	-5.86	-4.73	-3
Shares Outstanding (Basic)	2	1	1	1	0
Shares Outstanding (Diluted)	2	1	1	1	0
Shares Change (YoY)	56.90%	47.42%	60.61%	17.32%	-
EPS (Basic)	-6.94	-7.08	-6.80	-8.81	-6.56
EPS (Diluted)	-6.94	-7.08	-6.80	-8.81	-6.56
Gross Margin	49.99%	36.15%	-	-	-
Operating Margin	-43053.07%	-81800.98%	-	-	-
Profit Margin	-67538.16%	-127532.01%	-	-	-
EBIT	-7.2	-5.77	-3.47	-2.51	-2.3

Updated Feb 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.